|
|
|
|
5-Hydroxytryptophan
|
| |
|
| |
5-Hydroxytryptophan or 5-HTP is a naturally occurring amino acid, a precursor to the neurotransmitter serotonin and an intermediate in tryptophan metabolism. It is marketed in the United States and other countries as a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid, however, according to a 2001 meta-analysis, insufficient high quality research has been done to establish that it is efficacious.
droxytryptophan is decarboxylated to serotonin (5-hydroxytryptamine or 5-HT) by the enzyme aromatic-L-amino-acid decarboxylase with the help of Vitamin B6.
This reaction occurs both in nervous tissue and in the liver.

Discussion
Ask a question about '5-Hydroxytryptophan'
Start a new discussion about '5-Hydroxytryptophan'
Answer questions from other users
|
Encyclopedia
5-Hydroxytryptophan or 5-HTP is a naturally occurring amino acid, a precursor to the neurotransmitter serotonin and an intermediate in tryptophan metabolism. It is marketed in the United States and other countries as a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid, however, according to a 2001 meta-analysis, insufficient high quality research has been done to establish that it is efficacious.
Metabolism
5-Hydroxytryptophan is decarboxylated to serotonin (5-hydroxytryptamine or 5-HT) by the enzyme aromatic-L-amino-acid decarboxylase with the help of Vitamin B6.
This reaction occurs both in nervous tissue and in the liver. 5-HTP crosses the blood-brain barrier, while 5-HT does not. Excess 5-HTP, especially when administered with Vitamin B6, is thought to be metabolized and excreted.
Pharmacology
The psychoactive action of 5-HTP is thought to derive from its effect on serotonin synthesis in central nervous system tissue. It is believed that an artificially high supply of 5-HTP causes the brain's serotonin-producing neurons to increase production. Increased serotonin production then leads to increased serotonin release.
Research shows that co-administration with carbidopa greatly increases plasma 5-HTP levels. However, several studies have reported that 5-HTP is effective even without a peripheral decarboxylase inhibitor (e.g. carbidopa).
Other studies have indicated the risk of a scleroderma-like condition resulting from the combination of 5-HTP and carbidopa.
As a therapeutic supplement
5-HTP, which is found in minute amounts in certain foods like cheese and the white meat of poultry, is often sold as an over-the-counter therapeutic supplement. In this case, it is usually sourced from the seeds of Griffonia simplicifolia. 5-HTP in supplement form is typically sold in 50 mg or 100 mg gelatin or vegetarian capsules.
Research
A recent (2001) meta-analysis found that of 108 studies on 5-HTP published between 1966 and 2000, only two met the authors' quality standards for inclusion. The two studies that were deemed of sufficient quality did not deal with 5-HTP exclusively, instead combining results for 5-HTP and tryptophan, so the results may not be completely applicable for 5-HTP alone. While the combined analysis of the two 5-HTP and tryptophan studies showed significant effectiveness over placebo in treating depression, the authors state that overall "the evidence was of insufficient quality to be conclusive." They also state that "because alternative antidepressants exist which have been proven to be effective and safe the clinical usefulness of 5-HTP and tryptophan is limited at present."
Possible risks or side effects Because 5-HTP has not been thoroughly studied in a clinical setting, possible side effects and interactions with other drugs are not well known.
Due to the conversion of 5-HTP into serotonin by the liver, there is a significant risk of heart valve disease from serotonin's effect on the heart. In Europe, 5-HTP is prescribed with carbidopa to prevent the conversion of 5-HTP into serotonin until it reaches the brain.
Direct and indirect evidence for possible risks and side effects associated with 5-HTP:
In people:
- Heart valve damage or disease.
- When combined with MAO inhibitors, MDMA, Methylone, or other serotoninergic drugs 5-HTP may cause acute serotonin syndrome.
- When combined with carbidopa (as a treatment for symptoms of Parkinson's disease), 5-HTP causes nausea and vomiting; however this can be alleviated via administration of granisetron.
In animals:
- In rodents, 5-HTP administration is used in various experimental procedures to induce a "head twitch response" -- behaviour generally thought to be correlated with the animal experiencing hallucinations. There is no evidence however for a similar response in humans, at least when dosage is within the recommended daily levels.
- In rats, 5-HTP administration raises the risk of serotonin toxicity when given alongside other serotonergic drugs..
- When given to pregnant sheep, 5-HTP alters the behavior of the fetus.
See also
Further reading
|
| |
|
|